This question concerns many patients starting glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), or liraglutide (Victoza, Saxenda) for type 2 diabetes or weight management
Clinical studies have demonstrated promising effects on satiety, caloric intake, and metabolic health, while combination therapy with GLP-1 receptor agonists has shown even greater potential for obesity research
Alfieri CM, Evans-Anderson HJ, Yutzey KE (2007) Developmental regulation of the mouse IGF-I exon 1 promoter region by calcineurin activation of NFAT in skeletal muscle
This combined protocol remains the gold standard in secretagogue research
Among people who have never taken a GLP-1 for weight loss, 30% say the fact that the medication requires injections played a role in their decision not to start
FAQs GLP 1 Probiotic PRO